Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-223326
Filing Date
2022-08-17
Accepted
2022-08-17 17:00:55
Documents
1
Group Members
BCIP LIFE SCIENCES ASSOCIATES, LP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d381896dsc13da.htm SC 13D/A 47490
  Complete submission text file 0001193125-22-223326.txt   49027
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-80035 | Film No.: 221174971
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 617-516-2000
Bain Capital Life Sciences Fund, L.P. (Filed by) CIK: 0001687968 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A